Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2250 of 3546 entries
View as:

Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT04707391 Org: User:
Start: 01/25/21 End: 09/29/23 Due: 09/29/24

Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00097370 Org: User:
Start: 09/30/04 End: 09/29/10 Due: 09/29/11

Study to Evaluate the Safety of Co-administration of GSK Biologicals' Poliorix and Infanrix in Healthy Children in Russia

Phase: N/A Priority: Normal
NCT ID: NCT01094171 Org: User:
Start: 12/03/10 End: 10/27/12 Due: 10/27/13

A Randomized Study Evaluating Steroid Hormone Levels, Safety And Tolerability Of GW870086X In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00549497 Org: User:
Start: 09/30/07 End: 01/31/08 Due: 01/31/09

A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00437229 Org: User:
Start: 02/19/07 End: 05/15/07 Due: 05/15/08

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 65 Years of Age With and Without Zostavax® Vaccination at Least 5 Years Earlier

Phase: N/A Priority: Normal
NCT ID: NCT02581410 Org: User:
Start: 12/15/15 End: 08/01/17 Due: 08/01/18

A Study Of GW679769 Compared To Placebo In Women With Overactive Bladder

Phase: N/A Priority: Normal
NCT ID: NCT00321477 Org: User:
Start: 12/31/05 End: 02/28/07 Due: 02/28/08

Determination of the Absolute Bioavailability of GSK2118436 Following a Single Oral Dose Co-Administered With an Intravenous Radiolabelled Microtracer of GSK2118436 in Subjects With BRAF Mutant Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01340833 Org: User:
Start: 06/08/11 End: 09/12/11 Due: 09/12/12

Study of GSK Biologicals' Influenza Vaccine Arepanrix™ in Japanese Adults 65 Years of Age or Older

Phase: N/A Priority: Normal
NCT ID: NCT01114620 Org: User:
Start: 05/17/10 End: 12/09/10 Due: 12/09/11

SB-681323 In Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00320450 Org: User:
Start: 11/30/05 End: 10/31/06 Due: 10/31/07

MAGE-A3 Antigen-Specific Cancer Immunotherapeutic in Patients With Progressive Metastatic Cutaneous Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00706238 Org: User:
Start: 09/29/08 End: 01/19/11 Due: 01/19/12

A Photoxicity and Photoallergy Study of a Developmental Face Cream, Serum and Lotion

Phase: N/A Priority: Normal
NCT ID: NCT04006795 Org: User:
Start: 08/28/19 End: 10/11/19 Due: 10/11/20

IMI PROTECT(WP2): Antidepressants & Fractures

Phase: N/A Priority: Normal
NCT ID: NCT01587729 Org: User:
Start: 11/30/11 End: 07/31/14 Due: 07/31/15

Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02153320 Org: User:
Start: 09/05/05 End: 10/28/05 Due: 10/28/06

A Study to Evaluate Pharmacokinetics, Safety and Tolerability of Extended-release Bupropion Hydrochloride Tablets in Chinese Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02698553 Org: User:
Start: 05/23/16 End: 06/29/16 Due: 06/29/17

A Study to Evaluate Persistence of Immune Responses After Post-exposure Prophylaxis of Rabipur® (Purified Chicken-embryo Cell Rabies Vaccine) in Chinese Children

Phase: N/A Priority: Normal
NCT ID: NCT02991872 Org: User:
Start: 12/16/16 End: 03/12/17 Due: 03/12/18

Safety of GSK Biologicals' Infanrix-IPV+HibTM Vaccine in Healthy Vietnamese Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT01577732 Org: User:
Start: 12/08/12 End: 04/09/13 Due: 04/09/14

First Time in Human Study Using GSK2330672

Phase: N/A Priority: Normal
NCT ID: NCT01416324 Org: User:
Start: 06/15/11 End: 09/09/11 Due: 09/09/12

Safety and Immunogenicity of GlaxoSmithKline Biologicals Meningococcal Group B Vaccine When Administered Concomitantly With GlaxoSmithKline Biologicals MenACWY Conjugate Vaccine to Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT02106390 Org: User:
Start: 06/05/14 End: 10/14/16 Due: 10/14/17

Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study

Phase: N/A Priority: Normal
NCT ID: NCT02100618 Org: User:
Start: 01/31/15 End: 04/30/15 Due: 04/30/16

Evaluation of Safety of a Vaccine Against Cervical Cancer in Healthy Korean Females

Phase: N/A Priority: Normal
NCT ID: NCT01101542 Org: User:
Start: 07/01/10 End: 02/20/14 Due: 02/20/15

Evaluation of Non-typable Haemophilus Influenzae and Pneumococcal Protein Vaccine Formulations in Young Adults

Phase: N/A Priority: Normal
NCT ID: NCT00814489 Org: User:
Start: 01/08/09 End: 06/10/10 Due: 06/10/11

A Study Of The Effects Of CB2 Compound Of GW842166 In Patients With Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT00479427 Org: User:
Start: 07/06/07 End: 10/09/07 Due: 10/09/08

Evaluation of Oral Hygiene Products in an In Situ Caries Model

Phase: N/A Priority: Normal
NCT ID: NCT02399163 Org: User:
Start: 04/30/15 End: 08/31/15 Due: 08/31/16

Helium-3 MRI Imaging Study in COPD

Phase: N/A Priority: Normal
NCT ID: NCT02207452 Org: User:
Start: 08/05/10 End: 07/04/11 Due: 07/04/12